These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33740842)

  • 1. The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report.
    Kuzin M; Xepapadakos F; Scharrer I; Augsburger M; Eap CB; Schoretsanitis G
    Basic Clin Pharmacol Toxicol; 2021 Jul; 129(1):82-85. PubMed ID: 33740842
    [No Abstract]   [Full Text] [Related]  

  • 2. CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants.
    Zhang L; Sarangi V; Moon I; Yu J; Liu D; Devarajan S; Reid JM; Kalari KR; Wang L; Weinshilboum R
    Clin Transl Sci; 2020 Jul; 13(4):727-742. PubMed ID: 32004414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin-Induced Cutaneous Adverse Drug Reactions.
    Fohner AE; Rettie AE; Thai KK; Ranatunga DK; Lawson BL; Liu VX; Schaefer CA
    Clin Transl Sci; 2020 Sep; 13(5):1004-1009. PubMed ID: 32216088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
    Velazquez MNR; Parween S; Udhane SS; Pandey AV
    Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array.
    Jørgensen S; Brodersen T; Vesterager Pedersen OB; Westergaard N
    Basic Clin Pharmacol Toxicol; 2024 Aug; 135(2):217-222. PubMed ID: 38813766
    [No Abstract]   [Full Text] [Related]  

  • 6. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A; Dorado P; Fricke-Galindo I; Jung-Cook H; Monroy-Jaramillo N; Martínez-Juárez IE; Familiar-López I; Peñas-Lledó E; LLerena A; López-López M
    Pharmacogenomics J; 2016 Jun; 16(3):286-92. PubMed ID: 26122019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of polymorphic metabolism enzymes on serum phenytoin level.
    Ozkaynakci A; Gulcebi MI; Ergeç D; Ulucan K; Uzan M; Ozkara C; Guney I; Onat FY
    Neurol Sci; 2015 Mar; 36(3):397-401. PubMed ID: 25311916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid hyperemesis syndrome.
    Parekh JD; Wozniak SE; Khan K; Dutta SK
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome: The State of the Science.
    Lathrop JR; Rosen SN; Heitkemper MM; Buchanan DT
    Gastroenterol Nurs; 2023 May-Jun 01; 46(3):208-224. PubMed ID: 37074964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hot bath to calm what ails you: the Cannabis Hyperemesis Syndrome.
    Luther V; Yap L
    Acute Med; 2012; 11(1):23-4. PubMed ID: 22423343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.
    Iacopetti CL; Packer CD
    Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.
    Bahar MA; Setiawan D; Hak E; Wilffert B
    Pharmacogenomics; 2017 May; 18(7):701-739. PubMed ID: 28480783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel pharmacogenetics: associations between genotype and stent thrombosis risk in patients with stent placement.
    Ferrari M; Tozzi M; Marino F; Tarallo A; Riva F; Mirabile M; Castelli P; Cosentino M
    J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):46-48. PubMed ID: 30531616
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome.
    Bonnet U
    Med Princ Pract; 2022; 31(5):497-498. PubMed ID: 35817019
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclical hyperemesis secondary to cannabis abuse].
    Ochoa-Mangado E; Jiménez Giménez M; Salvador Vadillo E; Madoz-Gúrpide A
    Gastroenterol Hepatol; 2009; 32(6):406-9. PubMed ID: 19477551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient: Case Report.
    La Sala MS; Constantino E; Koola MM; Yel I; Chacko M
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):506-508. PubMed ID: 35943399
    [No Abstract]   [Full Text] [Related]  

  • 18. Community-based study of cannabis hyperemesis syndrome.
    Lewis B; Leach E; Fomum Mugri LB; Keung MY; Ouellette L; Riley B; Judge B; Fleeger T; Jones JS
    Am J Emerg Med; 2021 Jul; 45():504-505. PubMed ID: 34103168
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-term fasting alters cytochrome P450-mediated drug metabolism in humans.
    Lammers LA; Achterbergh R; de Vries EM; van Nierop FS; Klümpen HJ; Soeters MR; Boelen A; Romijn JA; Mathôt RA
    Drug Metab Dispos; 2015 Jun; 43(6):819-28. PubMed ID: 25795462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse].
    Naver AV; Theede K
    Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.